Homonymous Hemianopia Clinical Trial
Official title:
Community-based Multi-center Randomized Control Trial of Peripheral Prism Glasses for Hemianopia
Verified date | April 2017 |
Source | Massachusetts Eye and Ear Infirmary |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the functional utility for general mobility (walking) of new high power permanent peripheral prism glasses, which provide visual field expansion device for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes). The efficacy of real peripheral prism glasses will be assessed relative to sham peripheral prism glasses.
Status | Completed |
Enrollment | 73 |
Est. completion date | April 2010 |
Est. primary completion date | July 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - At least 18 years of age. - Sighted in both eyes, with monocular visual acuity (best corrected vision), of at least 20/50 in each eye. - Complete homonymous hemianopia of more than 3 months duration - Refractive error within the -5 dioptre to +5 dioptre range - No significant cognitive impairment - No history of wearing the Peli system of peripheral prisms for hemianopic field expansion (patients who have worn another type of prismatic correction for hemianopia such as yoked prisms or the Gottlieb VAS system can participate in the study) - No physical or mental disabilities, including cognitive dysfunction, balance problems or other deficits that could impair ability to walk or use the peripheral prism spectacles. - Able to walk (using a cane or walker is OK) or control the movements of their own wheelchair. - In sufficiently good health to attend four in-office visits. Exclusion Criteria: - Diagnosis of dementia - Diagnosis of visual neglect - History of seizures in the last 6 months - Incomplete hemianopia |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Manchester Royal Eye Hospital | Manchester | |
United States | Emory Optical Low Vision | Atlanta | Georgia |
United States | UAB Center for Low Vision Rehabilitation | Birmingham | Alabama |
United States | Indiana University School of Optometry, Low Vision Rehabilitation and Primary Care Services | Bloomington | Indiana |
United States | Schepens Eye Research Institute | Boston | Massachusetts |
United States | Illinois Eye Institute | Chicago | Illinois |
United States | Academy Eye Associates | Durham | North Carolina |
United States | Visual Health@Jupiter Eye Center | Jupiter | Florida |
United States | Vista Center for the Blind and Visually Impaired | Palo Alto | California |
United States | University of Kansas Medical Center | Prairie Village | Kansas |
United States | Vision Care Specialists, P.C. | Southborough | Massachusetts |
United States | NSU Oklahoma College of Optometry, | Tahlequah | Oklahoma |
United States | Seven Lakes Eye Care | West End | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Alexandra Bowers | Chadwick Optical Inc., National Eye Institute (NEI) |
United States, United Kingdom,
Bowers AR, Keeney K, Peli E. Community-based trial of a peripheral prism visual field expansion device for hemianopia. Arch Ophthalmol. 2008 May;126(5):657-64. doi: 10.1001/archopht.126.5.657. — View Citation
Peli E. Field expansion for homonymous hemianopia by optically induced peripheral exotropia. Optom Vis Sci. 2000 Sep;77(9):453-64. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall Proportion Saying "Yes" to Real Prism Glasses | At the end of each crossover period, participants were asked a yes/no question: "If the study were to end today, would you want to continue with these prism glasses (i.e. the prism glasses worn in that period)?" The primary outcome was the overall difference, across the two periods of the crossover, between the proportion of participants saying "yes" to real prism glasses and the proportion saying "yes" to sham prism glasses. | Evaluated after 4 weeks of wearing each type of prism glasses | |
Secondary | Mobility Change Score (All Participants Who Completed Crossover) | Perceived difficulties with mobility were quantified using a 5-point rating scale (no difficulty to extreme difficulty) for 7 situations (items) relevant to people with hemianopia, including at home, in stores, outdoors, in unfamiliar areas, in familiar areas, in crowded areas, and noticing objects off to the side when walking. The questionnaire was administered at baseline (without prisms) and after each period of the crossover. Interval scale measures of perceived difficulty with overall mobility for each participant were estimated using Rasch analysis of the responses to all seven items (Winsteps software, version 3.70.0.226). Rasch measures were expressed as logits (log odds ratios). Mobility change scores for real and sham prisms were defined as the difference in perceived difficulty relative to baseline (in logits). | Evaluated after 4 weeks of wearing each type of prism glasses | |
Secondary | Mobility Change Score (Only Participants Who Continued Prism Wear in the Long Term) | Perceived difficulties with mobility were quantified using a 5-point rating scale (no difficulty to extreme difficulty) for 7 situations (items) relevant to people with hemianopia, including at home, in stores, outdoors, in unfamiliar areas, in familiar areas, in crowded areas, and noticing objects off to the side when walking. The questionnaire was administered at baseline (without prisms) and after each period of the crossover. Interval scale measures of perceived difficulty with overall mobility for each participant were estimated using Rasch analysis of the responses to all seven items (Winsteps software, version 3.70.0.226). Rasch measures were expressed as logits (log odds ratios). Mobility change scores for real and sham prisms were defined as the difference in perceived difficulty relative to baseline (in logits). | Evaluated after 4 weeks of wearing each type of prism glasses | |
Secondary | Mobility Change Score (Only Participants Who Discontinued Prism Wear in the Long Term) | Perceived difficulties with mobility were quantified using a 5-point rating scale (no difficulty to extreme difficulty) for 7 situations (items) relevant to people with hemianopia, including at home, in stores, outdoors, in unfamiliar areas, in familiar areas, in crowded areas, and noticing objects off to the side when walking. The questionnaire was administered at baseline (without prisms) and after each period of the crossover. Interval scale measures of perceived difficulty with overall mobility for each participant were estimated using Rasch analysis of the responses to all seven items (Winsteps software, version 3.70.0.226). Rasch measures were expressed as logits (log odds ratios). Mobility improvement scores for real and sham prisms were defined as the difference in perceived difficulty relative to baseline (in logits). | Evaluated after 4 weeks of wearing each type of prism glasses |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04827147 -
Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia
|
N/A | |
Enrolling by invitation |
NCT06115317 -
Homonymous Hemianopia in Childhood
|
N/A | |
Not yet recruiting |
NCT06136169 -
Reminder-cue Scanning Training for Homonymous Visual Field Loss
|
N/A | |
Recruiting |
NCT05141604 -
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
|
N/A | |
Completed |
NCT01372332 -
Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)
|
N/A | |
Recruiting |
NCT04798924 -
Visual Rehabilitation After Occipital Stroke
|
N/A |